OAGeneral-header-areyouready

¿Se ha decidido por DUROLANE para su terapia de ácido hialurónico?

¿DUROLANE es adecuado para usted?

Le pueden recetar DUROLANE si:

  1. Le han diagnosticado osteoartritis de leve a moderada32
  2. Le han diagnosticado osteoartritis en la rodilla, cadera, hombro, tobillo, muñeca, dedos de la mano o dedos de los pies*32
  3. No responde a los tratamientos alternativos para la osteoartritis6
  4. Tiene alergia a los productos de origen animal y necesita un producto sintético6
  5. Tiene motivación para volver a sus actividades diarias normales
  6. Busca retrasar la cirugía de reemplazo articular con un tratamiento seguro para un uso repetido a lo largo del tiempo2,10
  7. No es candidata/o a cirugía y necesita un tratamiento no operatorio para un alivio duradero del dolor2,4,10
  8. Trata de reducir su uso de AINE y analgésicos9,37
  9. Trata de evitar inyecciones repetidas de corticosteroides4

Muchos factores pueden influir en las terapias para la OA que mejor funcionen para usted. Por lo tanto, hable con su médico para averiguar si DUROLANE debe formar parte de su línea de tratamiento.

Obtenga más información sobre DUROLANE y lea nuestras preguntas frecuentes.

Summary of Indications for Use

DUROLANE (3 mL): Argentina, Australia,* Brazil, Chile, Colombia, EU,* India, New Zealand,* Russia, Switzerland,* Turkey,* United Arab Emirates: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in Australia, EU and New Zealand for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

Mexico: Symptomatic treatment of mild to moderate knee osteoarthritis.

Taiwan: Treatment of pain in OA of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. In addition, DUROLANE has been licensed for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

*DUROLANE is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

Full prescribing information can be found in product labeling.

Summary of risks: You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling.

Summary of Indications for Use for Curavisc: Curavisc (2 mL): EU, Brazil, Egypt, Malaysia: Pain and disturbed function in degenerative and traumatic disease of the joints. Curavisc can be used for large joints, e.g., knee, hip, or shoulder joint. Treatment course of 3- injections, up to 5- injections.

Summary of risks: You should not use CURAVISC if you have infections or skin disease at the injection site. CURAVSIC has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling and on the website at bioventus.com/curavisc.com.